1. Home
  2. NRSN vs BYFC Comparison

NRSN vs BYFC Comparison

Compare NRSN & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • BYFC
  • Stock Information
  • Founded
  • NRSN 2017
  • BYFC 1946
  • Country
  • NRSN Israel
  • BYFC United States
  • Employees
  • NRSN N/A
  • BYFC N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • BYFC Savings Institutions
  • Sector
  • NRSN Health Care
  • BYFC Finance
  • Exchange
  • NRSN Nasdaq
  • BYFC Nasdaq
  • Market Cap
  • NRSN 58.8M
  • BYFC 63.8M
  • IPO Year
  • NRSN 2021
  • BYFC 1996
  • Fundamental
  • Price
  • NRSN $1.91
  • BYFC $7.28
  • Analyst Decision
  • NRSN Buy
  • BYFC
  • Analyst Count
  • NRSN 2
  • BYFC 0
  • Target Price
  • NRSN $14.00
  • BYFC N/A
  • AVG Volume (30 Days)
  • NRSN 442.8K
  • BYFC 7.4K
  • Earning Date
  • NRSN 07-11-2025
  • BYFC 07-29-2025
  • Dividend Yield
  • NRSN N/A
  • BYFC N/A
  • EPS Growth
  • NRSN N/A
  • BYFC N/A
  • EPS
  • NRSN N/A
  • BYFC N/A
  • Revenue
  • NRSN N/A
  • BYFC $32,732,999.00
  • Revenue This Year
  • NRSN N/A
  • BYFC N/A
  • Revenue Next Year
  • NRSN N/A
  • BYFC N/A
  • P/E Ratio
  • NRSN N/A
  • BYFC N/A
  • Revenue Growth
  • NRSN N/A
  • BYFC N/A
  • 52 Week Low
  • NRSN $0.51
  • BYFC $4.68
  • 52 Week High
  • NRSN $2.60
  • BYFC $9.46
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 51.18
  • BYFC 69.81
  • Support Level
  • NRSN $2.04
  • BYFC $5.92
  • Resistance Level
  • NRSN $2.35
  • BYFC $6.68
  • Average True Range (ATR)
  • NRSN 0.25
  • BYFC 0.25
  • MACD
  • NRSN -0.04
  • BYFC 0.10
  • Stochastic Oscillator
  • NRSN 28.74
  • BYFC 68.12

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

Share on Social Networks: